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Abstract
Design and objective: This paper describes the protocol for a large-scale pragmatic, randomised controlled trial and
economic evaluation to investigate the effectiveness and cost-effectiveness of the self-directed E-Couch social anxiety
module versus a waiting list control condition, for reducing sub-clinical social anxiety symptoms in the general population.
Study population: Community-based adults (aged 18þ) with social anxiety symptoms that do not meet the criteria for social
anxiety disorder recruited via a direct-to-consumer advertisement on national websites.
Intervention and control: Intervention is the self-guided E-Couch social anxiety module. Control group participants are placed
on a waiting list to receive the intervention at the end of the trial. Both groups receive email and text message reminders.
Outcome measures: The primary outcome will be change in self-reported social anxiety score using the Social Phobia Inventory
(SPIN). Secondary outcomes will be the changes in the following self-report measures: Brief Fear of Negative Evaluation scale
(BFNE-S); depression (CES-D); mental wellbeing (SWEMWEBS); health status (SF36); use of health services; safety events; and
adherence, retention, and attrition rates. All measures will be administered at baseline, 6 weeks, and 3, 6 and 12 months.
Analysis: A mixed effects model will be used to analyse the effect of the intervention on the primary and secondary
outcomes (intention to treat analysis). Secondary analyses will explore moderators and mediators of effect. A prospective
economic evaluation, conducted from a NHS and social care perspective, will provide estimates of cost utility and cost-
effectiveness. An interview study will be conducted with 20 participants to explore issues including acceptability, adherence,
retention and attrition.
Trial registration numbers: NCT02451878 and ISRCTN15819951
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Introduction
The internet is playing an ever more important role in
our social and emotional lives. The proliferation and
widespread adoption of connected devices such as
smartphones and tablet computers are leading to an
‘always on’ culture where people are becoming used
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to accessing online content for many public and private
services, from any location. People go online in large
numbers to find self-help solutions for a range of phys-
ical and mental health problems, and for broader
health-related activities such as diet and exercise.1
Delivering self-help tools using online platforms offers
a low-cost and highly scalable approach that could
potentially be harnessed by public health practitioners
and policymakers seeking to tackle population-wide
problems.2 However, the public health community has
been slow to capitalise on this opportunity, and in gen-
eral the pace of innovation has run ahead of both pol-
icymakers and evaluators. Thus, for many of these
online self-help approaches, we do not have good evi-
dence as to whether they are helpful or not, despite
their wide use.
Social anxiety is a major public health problem
that often goes unrecognised and untreated.
Epidemiological studies indicate that social anxiety dis-
order is one of the more common mental disorders,
with a 1-year prevalence of 4%6%3 and a lifetime
prevalence of up to 12%.4 It is characterised by an
intense and persistent fear of being negatively evaluated
in social or performance situations. Effective treatments
exist for social anxiety disorder. The National Institute
for Health and Care Excellence (NICE) guideline on
the assessment and treatment of social anxiety disorder5
recommends that all NHS patients diagnosed with
social anxiety disorder should be offered a course of
individual cognitive behavioural therapy based on
either the Clark and Wells or the Heimberg model of
treatment.5
Substantially less attention has been directed to sub-
clinical social anxiety, in which symptoms do not reach
the criteria for a diagnosis. Nevertheless, such social
anxiety symptoms cause significant problems and cost
at the individual and societal levels, with many people
not fulfilling their potential due to avoidance of social
situations, which affects their relationships and educa-
tional and occupational achievements. Accordingly, the
current study is focused on sub-clinical social anxiety
symptoms that do not reach the criteria for a diagnosis
of the disorder.
There are currently no official diagnostic criteria for
sub-clinical anxiety. At present, a score of 20 or above
on the validated Social Phobia Inventory (SPIN) self-
report questionnaire indicates clinical social anxiety.
The population mean for SPIN is 11 or 12 (in previous
studies). Based on this general population data, a range
of 1319 on the SPIN might be appropriate to capture
people with sub-clinical social anxiety. The prevalence
and impact of falling into the sub-clinical range are not
currently known.
In this study we will test the benefit of a novel public
health approach of online self-help to reduce the level
of sub-clinical symptoms in the general population.
A public health approach is appropriate, as sub-clinical
social anxiety symptoms are very common and are con-
tinuously distributed throughout the population, and
many people could potentially benefit from an access-
ible intervention to reduce these sub-clinical symptoms.
Also, while there is evidence that therapist-guided inter-
net-based social anxiety applications are effective as
treatments, little is known about the effectiveness of
fully self-directed interventions, which are becoming
ever more available. This study will contribute to the
evidence on the self-help delivery model, at least for a
sub-clinical population.
Further aims of our work will be to learn more
about the benefits and challenges of harnessing the
internet to deliver public health interventions, and to
explore methodological issues in undertaking large-
scale online public health trials. This will include
exploring issues of recruitment, acceptability, retention
and attrition.
Background
E-Couch (https://ecouch.anu.edu.au) is an online tool-
kit of self-directed modules covering common mental
health problems including social anxiety, generalised
anxiety, depression, relationship breakdown, and loss
and grief. It was developed by researchers at the
Australian National University (ANU). The social anx-
iety module is based on cognitive behavioural therapy
principles and includes components of known effective-
ness in face-to-face therapy. It contains a literacy sec-
tion and five toolkits comprising exposure practice,
cognitive restructuring (modifying your thinking),
attention practice, social skills training and relaxation.
E-Couch is designed to be completed at the partici-
pant’s own pace. It is free to use, browser-based and
widely accessible on a range of connected devices.
Analysis of unpublished data collected from spontan-
eous visitors from around the world to the publicly
accessible E-Couch site shows a statistically significant
reduction in social anxiety symptoms among visitors to
the social anxiety toolkit. For unguided self-help,
higher credibility ratings of a treatment program have
been shown to be associated with increased treatment
adherence in patients with social anxiety disorder.6 We
are interested in whether the social anxiety module is
effective in people with sub-clinical social anxiety
symptoms.
We are not aware of any previous studies of online
self-help for sub-clinical social anxiety symptoms. In a
small (n¼ 63) laboratory-based randomised controlled
trial with individuals with high levels of social anxiety,
Bowler et al. (2012) showed that the social phobia mod-
ules of the E-Couch toolkit resulted in a significantly
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greater reduction in social anxiety than control (effect
size d¼ 1.0).7 Although there was no formal face-
to-face therapeutic input in this context, the study did
ensure that participants completed the set modules.
Thus, to date, there have been no controlled studies
of the intervention with a fully self-guided approach.
To date, there have only been two trials comparing
therapist-guided with unguided (or self-guided)
internet-based treatment of social anxiety disorder.
Undertaken by Titov et al. (2008), an intention-
to-treat (ITT) analysis found that the unguided
intervention was not effective relative to control.
However, there was evidence that the program was
helpful for the participants who completed the interven-
tion.8 Berger et al.9 found that the internet therapy
led to symptom reduction in both the therapist-
guided and self-guided groups. Both studies highlighted
the scope for internet-delivered treatment for social
phobia.
A Cochrane review of media-delivered cognitive
behavioural therapy (CBT) and behavioural therapy
(BT) interventions for anxiety10 identified 15 studies
of social anxiety disorder compared with no treatment.
The meta-analysis of these studies found a significant
benefit of the interventions, with a standard mean dif-
ference of 0.73 (95% confidence interval 0.59 to 0.87)
favouring the media-delivered therapy. The Cochrane
review identified four studies that compared a media-
delivered intervention with face-to-face therapy, finding
no significant difference in treatment effect (standard
mean difference 0.02, 95% confidence interval 0.18
to 0.22). The authors noted that the effect sizes
(for all anxiety interventions combined, not only
social anxiety disorder) for these media-based interven-
tions were greatest for internet-delivered CBT. The
authors further noted that studies varied greatly in
the level of therapist contact (if any) provided to the
intervention group, and noted that while therapist
contact was beneficial in a trial setting, it may not be
practical for a pragmatic population-based approach to
service delivery. The authors suggest that fully self-
directed tools may have a role for those at the begin-
ning of a stepped care pathway.
In summary, there is evidence that internet-based
cognitive behavioural therapy for social anxiety dis-
order is effective; however, there is a lack of evidence
on the value of self-guided internet interventions such
as E-Couch with no therapist contact, and no evidence
in sub-clinical populations. The self-guided approach
requires further research, particularly given the
potential resource savings over the therapist-guided
approach if widely disseminated across the population,
and the fact that many fully self-guided interventions,




A large pragmatic randomised controlled trial of
the internet-based self-directed E-Couch social
anxiety module versus a waiting list control
condition, for the treatment of sub-clinical social
anxiety symptoms, among a general population
sample recruited from the UK population using
direct-to-consumer advertisements placed on national
websites.
Intervention
The E-Couch toolkit is available online for anyone who
registers to use it (https://ecouch.anu.edu.au). For this
study, a social anxiety-specific tool will be packaged
using the E-Couch social anxiety content to create the
intervention. We do not anticipate high levels of con-
tamination in the control arm  we will not name the
intervention ‘E-Couch’ in the study information (it will
be referred to as an ‘online self-help program’), and
E-Couch (and the social anxiety elements within the
toolkit) are not widely known or used by the UK popu-
lation. We will measure contamination through
participant self-report at the time of final follow-up.
This is a pragmatic study, and we would expect some
participants to be also seeking other self-help, in both
arms of the study.
Control group
Participants in the control group receive no interven-
tion and are placed on a waiting list to receive the inter-
vention at the end of the trial.
Study population
Internet users who consent to take part in a study
for self-help with sub-clinical social anxiety symptoms.
Individuals who are likely to have social anxiety
disorder (as judged by scoring >19 on the self-
completion 17-item SPIN screening measure)11 will be
given advice to seek help from health services for social
anxiety disorder, for which evidence-based treatments
exist.
Recruitment
We will recruit participants through advertise-
ments placed on public websites providing health infor-
mation, including the NHS website. This is a widely
trusted source of health information, and the NHS
branding is known to facilitate recruitment to research
studies.12
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Eligibility screening and consent
Individuals expressing an interest in the online adver-
tisement by clicking on a web link will be directed to a
study website containing full information on the trial
and the opportunity to ask questions of the study team
by email or telephone.
In line with our public health approach and the
pragmatic nature of this study, our inclusion criteria
will be kept very broad. Potential participants will be
invited to complete screening questions that will deter-
mine whether they are eligible for participation. In the
preliminary screening phase they will need to confirm
the following: availability of a working email address
(to respond to a confirmation email and receive remin-
ders), availability of a mobile phone number (to receive
text reminders), and that they are aged 18 or over and
resident in the UK. We will exclude people who are
currently receiving therapist-guided treatment for
social anxiety disorder. Those who meet these prelim-
inary screening criteria will be asked to provide online
consent for the next phases of the study, including con-
sent to complete screening measures and to be rando-
mised to one of two conditions. Participants will be
advised that they are free to withdraw at any time with-
out giving a reason and that this will not affect their
care. There are no discontinuation criteria apart from
participant request.
Once individuals have completed the preliminary
screening and consent process, they will be asked to
complete the SPIN. If they score in the range 1319
on the SPIN, they will be eligible for the trial as
having sub-clinical social anxiety symptoms, and will
be invited to complete the baseline measures described
below. Based on the general population data available to
us, the range of SPIN 1319 was chosen to capture those
people who score above the population mean (usually 11
or 12 in previous studies). If they score 20 or more, they
will be excluded from the trial and given advice on seek-
ing help. We will recontact these people (with their con-
sent, by email) 1 month later to determine whether they
have acted on our advice and sought other help. The
follow-up email will ask them whether they have, and
what help they have sought. At the time we send this
email, we will also include repeat advice on how to seek
help and what effective treatments are available. As there
is no accepted screening approach for identifying people
with sub-clinical symptoms, we will monitor recruitment
and the performance of the SPIN tool. Recruitment was
planned to start in April 2016 and last for 6 months.
Initial trial flow and collection of
baseline measures
In addition to the SPIN, eligible participants will be
asked to complete a battery of self-report baseline
questionnaires, and in line with all other trial proced-
ures, these will be collected online through the trial
portal. These questionnaires will collect demo-
graphic characteristics (age, gender, marital status,
education, employment, income, ethnicity and coun-
try of residence), and we will measure social anxiety
symptoms (SPIN and Brief Fear of Negative
Evaluation (BFNE-S) scale), depression (Center for
Epidemiologic Studies Depression (CES-D)), mental
wellbeing (Short Warwick-Edinburgh Mental Well-
being Scale (SWEMWBS)), health status (Short Form
Health Survey (SF-36)), and current use of health ser-
vices and psychological interventions (including self-
help).
Once baseline measures are completed, eligible par-
ticipants will be randomised in a 1:1 ratio with no
stratification, using a computer-generated random
number sequence run through an automatic online pro-
gram. Participants in the intervention arm will be given
access to a password-protected website and will be
encouraged to access and use the self-guided interven-
tion over a period of up to 6 weeks (although they can
work through the intervention at their own pace).
A major lesson from our previous work on fully self-
directed online interventions13 is that internet trial
recruitment tends to be ‘easy in, easy out’ with high
levels of attrition. We will use automated text (SMS)
message and email reminders to reduce attrition.
Participants will receive one text message within
24 hours of randomisation to thank them for partici-
pating and to remind them to access the intervention,
and one further text message towards the end of the
6-week period to thank them again and to remind
them that they will shortly be asked to complete
follow-up measures. They will also receive three email
reminders during the 6-week period (both intervention
and control groups will receive the reminders at 1 week,
3 weeks and 5 weeks). Participants in the control arm
will receive the same reminders for follow-up measures
and will be given access to the intervention after final
follow-up (12 months). Participants in the intervention
arm will be offered continued access to the intervention
once the trial is completed. Given that participants
either receive the intervention or are on the waiting
list, participants will not be blind to allocation.
Researchers undertaking the analysis will be blind to
allocation.
Follow-up measures
Self-report follow-up measures of social anxiety symp-
toms (SPIN and BFNE-S scales), depression (Center
for Epidemiologic Studies Depression Scale Revised
(CESD-R)), mental wellbeing (Short Warwick-
Edinburgh Mental Well-Being Scale (SWEMWBS)),
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health status (SF-36), current use of health services and
psychological interventions, and time off from work or
study due to psychological problems will be taken at 6
weeks (following completion of the self-guided interven-
tion), 3 months, 6 months and 12 months. At each
follow-up point they will receive notification of follow-
up measures by email and by text message, and if meas-
ures are not completed they will receive up to three
follow-up emails. We will also record website usage
data and measures of adherence to the intervention
(numbers of logins and modules completed), and attri-
tion from the trial (loss to follow-up at each time point).
Weekly reports will be generated to track these factors.
We will also record any safety (adverse) events  in this
study, these are likely to be self-reported and captured in
correspondence from participants. Since participant
information and measures are collected online, they
are automatically entered into a coded spreadsheet.
This dataset will be transferred to a statistical software
package for analysis, and data management checks will
be carried out to ensure data quality. All participant
information and measures will be stored securely, all
data transfers will be encrypted, only members of the
research team will have access to data, and all analyses
will only use anonymised datasets.
Primary outcome
The primary outcome is the change from baseline
in self-reported social anxiety as measured by the
SPIN-17. The SPIN is a self-report questionnaire that
includes 17 items assessing symptom domains of social
anxiety. A high score indicates greater severity of social
anxiety. This measure has been shown to have adequate
internal consistency, testretest reliability, construct
validity and sensitivity to change following interven-
tion.14 Change in SPIN-17 from baseline will be com-
puted for each post-randomisation time point.
Secondary outcomes
The secondary outcomes are fear of negative evaluation
measured using the eight-item BFNE-S scale;15 depres-
sion using the 20-item CESD-R;16 mental wellbeing
using the seven-item version of the WEMWBS tool
(SWEMWBS);17 general health status using the SF36,
including both mental and physical component scores
(MCS and PCS);18 and safety events.
Sample size
Although previous studies have reported a large treat-
ment effect for supported internet-delivered interven-
tions, we believe this treatment effect is too optimistic
for a self-guided treatment in a sub-clinical population
group, and is also likely to be smaller in pragmatic
settings. For this reason, we intend to recruit 2104 par-
ticipants (1052 per group) to this trial, which will pro-
vide 90% power to detect a small between group effect
size of Cohen’s d¼ 0.2 at the 5% two-sided significance
level. Although small at the level of the individual, such
effects can translate into potentially large benefits
across a population. This sample size has also
accounted for a high level of potential attrition of up
to 50% (although we aim to mitigate this, we need to be
realistic about self-guided internet interventions and the
likely level of attrition).
Statistical methods
The primary analysis will follow an ITT analysis. The
researchers will endeavour to obtain full follow-up data
on all participants to allow a full ITT analysis, but it is
very likely that a modified ITT analysis will be carried
out where data is missing due to withdrawal, loss to
follow up or non-response to some questionnaire
items. A modified ITT will include all participants
with at least one outcome assessment. We will explore
the mechanism of missing data by looking for associ-
ations between participant characteristics and the like-
lihood of non-response to questionnaires at different
time points. This can be done using a regression
model for binary outcomes (1¼ response; 0¼non-
response). If significant associations are observed, this
lends weight to a missing at random (MAR) assump-
tion. The primary outcome analysis will utilise a mixed
effects model, which implicitly accounts for data under
a MAR assumption.
We will perform sensitivity analysis for the primary
outcome using methods that do not assume a MAR
mechanism, such as pattern-mixture models, to assess
the robustness of this assumption. If different results
are obtained from a pattern-mixture model compared
with the mixed effects model, it is likely that the MAR
assumption is not valid. As this is a public health inter-
vention for people who are not ill, a per-protocol ana-
lysis will also be undertaken to explore the effect of the
intervention on participants who complete at least one
module of the intervention and have at least one out-
come assessment.
Two-sided significance tests will be carried out and
95% confidence intervals will be reported for estimates
of treatment effect. The trial results will be reported
in accordance with the Consolidated Standards
of Reporting Trials (CONSORT) statement.19 A
CONSORT flow chart detailing the number of partici-
pants screened, randomised and available for the ana-
lysis of the primary outcome will be presented. Reasons
for withdrawal, exclusions or losses to follow-up will be
shown at each stage of the study by randomised group.
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A mixed effects linear model will be fitted to the
primary outcome data. This model will utilise data col-
lected at baseline, 6 weeks, and 3, 6 and 12 months
following randomisation. The secondary outcomes
(fear of negative evaluation, depression, mental well-
being and general health) will follow the analysis for
the primary outcome. Potential adverse events self-
reported by the participants will be presented by ran-
domised group.
Further analyses will include sensitivity analyses to
explore the impact of missing data, and subgroup ana-
lyses to investigate factors that may moderate the effect
of the intervention or influence adherence. For both
primary and secondary outcomes, we will include sub-
group analyses of baseline factors that may influence
the intervention effect (moderators). Baseline sub-
groups will be compared by including interaction
terms in the model (baseline subgroup by treatment
group interaction). Baseline factors to be compared
include age, gender, educational level and baseline
level of sub-clinical social anxiety symptoms
Mediation analyses will also be undertaken to deter-
mine whether there is a doseresponse effect of the
intervention, with more interaction with the website
equating to higher levels of treatment effect (examining
‘dose’ in terms of total usage of site and numbers of
modules completed). For both groups, their usage
of the intervention will be recorded (total number of
logins to site, total time on site and total number of
modules completed). These will be tallied so that the
total at 6 weeks and 3, 6 and 12 months can be com-
puted and used in the analysis. We will also undertake
mediation analyses to explore the effect of receiving
other help for sub-clinical social anxiety symptoms
during the trial on the treatment effect observed. If
the program is effective, those randomised to the con-
trol condition may be more likely to seek additional
help elsewhere  a possible source of confounding
that has the potential to reduce the observed effect. In
addition, we will use a mediation model20,21 to assess
the influence of adherence/compliance to treatment
outcome.
Economic evaluation
A prospective economic evaluation, conducted from an
NHS and social care perspective, will be integrated into
the trial to assess cost and cost-effectiveness of the self-
guided internet-based intervention for people with sub-
clinical social anxiety symptoms.
People currently receiving treatment for social anx-
iety are excluded from the study, and the intervention
targets people who are unlikely to pursue help from
NHS or social care for their anxiety. Therefore, we
do not expect to see a significant direct impact on
health and social care costs. We are particularly inter-
ested in whether suffering from these symptoms may
impact on people’s productivity due to, for example,
absence from work or study.
We intend to estimate the costs of developing,
delivering and maintaining the intervention. Health ser-
vice and social care utilisation data will be collected
through participant self-report. Unit costs for service
utilisation will be derived from standard national
sources. Costs will be standardised to current prices
where possible.
The effectiveness of the intervention will be mea-
sured using quality-adjusted life years (QALYs) with
the under the curve approach. Health status will be
measured at all time points using the SF-36, converted
into SF-6D health utilities using established UK-based
utility algorithms and combined with time duration
data. The results of the economic evaluation will pri-
marily be expressed in terms of incremental cost per
QALY gained between the intervention and control
groups. Non-parametric bootstrap estimation will be
used to calculate 95% confidence intervals for mean
difference of cost and QALYs between the trial
groups, and incremental cost-effectiveness ratios.
Sensitivity analyses will explore the implications of
uncertainty on the incremental cost-effectiveness
ratios and will consider the broader issue of the gener-
alisability of the results.
Qualitative study
We will collect data on initial views and experiences of
the intervention at 6 weeks for all participants in the
intervention arm by providing a free text box at the end
of collecting outcomes measures. An in-depth qualita-
tive interview study will also be conducted with a subset
of approximately 20 participants in the intervention
arm at the 12-month follow-up. A maximum-variation
sampling technique will be used to select a diverse
sample of potential interviewees based on demographic
information and degree of completion of the interven-
tion. Interviews will be audio recorded, will last
approximately 1 hour and will be conducted in the par-
ticipant’s home or (if it is inconvenient or impractical to
conduct a home visit) by telephone. They will follow a
semi-structured topic guide, which will be piloted.
Interview transcripts will be analysed iteratively and
thematically using a constant comparative approach,
to explore issues related to acceptability, usability,
adherence, attrition, and perceived value and impact
of the intervention. In addition, we will invite partici-
pants who withdraw from the study to take part in a
short interview about reasons for withdrawal to explore
barriers to taking part in an online-only study and the
trial process as well as intervention-specific issues.
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Data sharing
After analyses are complete, the datasets will be made
available from the corresponding author on reasonable
request.
Dissemination
All trial results will be written up by the research team
in academic publications and also made available in lay
summary format on the trial webpages where partici-
pants can see them. The funders and the ethics commit-
tees will receive a final report. Authorship will comply
with International Committee of Medical Journal
Editors guidelines.
Contributorship: JP and KG conceived the study and are co-prin-
cipal investigators. All other authors contributed to writing the
protocol and revising the manuscript.
The trial sponsor is the University of Oxford, Joint Research Office,
Block 60, Churchill Hospital, Old Road, Headington, Oxford, OX3
7LE. The Oxford Primary Care Clinical Trials Unit standard operat-
ing procedures apply to the conduct of the trial. The research team
have responsibility for the study design; collection, management, ana-
lysis, and interpretation of data; writing of the report; and the deci-
sion to submit the report for publication. The funder and sponsor do
not have authority over these activities.
The study is overseen by an independent Trial Steering Committee
(TSC). In this low-risk population-based study of a self-help inter-
vention, the TSC also has the role of data monitoring. The TSC is
chaired by Dr Peter Davidson of the University of Southampton and
includes an independent trial statistician.
Declaration of Conflicting Interests: The author(s) declared the
following potential conflicts of interest with respect to the research,
authorship, and/or publication of this article: KG, KB and AB were
involved in the development of the E-Couch program and are
employed by the Australian National University, which delivers the
program to users worldwide.
Ethical approval: We received ethics committee approvals from
both the University of Oxford and the Australian National
University. The trial protocol is registered with ClinicalTrials.gov
(NCT02451878) and with ISRCTN (ISRCTN15819951). This paper
describes version 2 of the protocol, dated 18 February 2016.
Funding: The author(s) disclosed receipt of the following financial
support for the research, authorship, and/or publication of this article:
This work was supported by the MQ charity under its PsyIMPACT
funding call (www.joinMQ.org). KG is supported by NHMRC
Fellowship 1059620. The ongoing delivery of E-Couch is enabled by
funding from the Australian Commonwealth Department of Health.
HA was funded by a NIHR National School for Primary Care
Research Fellowship (up to September 2015). LL and YY are funded
by the NIHR Oxford Biomedical Research Centre (Oxford BRC).
Guarantor: JP is guarantor.
Peer review: The authors have chosen for the 2 individuals who
reviewed this manuscript to remain anonymous.
References
1. Pew Research Center. Health Fact Sheet. http://www.pew
internet.org/fact-sheets/health-fact-sheet/ (2013, accessed 8
March 2016).
2. Wilson GT and Zandberg LJ. Cognitivebehavioral
guided self-help for eating disorders: Effectiveness and
scalability. Clin Psychol Rev 2012; 32: 343357.
3. Griffiths KM. Towards a framework for increasing help-
seeking for social anxiety disorder. Aust N Z J Psychiatry
2013; 47: 899903.
4. Kessler RC, Berglund P, Demler O, et al. Lifetime preva-
lence and age-of-onset distributions of DSM-IV disorders
in the National Comorbidity Survey Replication. Arch
Gen Psychiatry 2005; 62: 593602.
5. NICE. Social anxiety disorder: Recognition, assessment
and treatment. Clinical Guideline 159. http://www.nice.
org.uk/guidance/cg159 (2013, accessed 8 March 2016).
6. Nordgreen T, Havik OE, O¨st LG, et al. Outcome pre-
dictors in guided and unguided self-help for social anxiety
disorder. Behav Res Ther 2012; 50: 1321.
7. Bowler JO, Mackintosh B, Dunn BD, et al. A compari-
son of cognitive bias modification for interpretation and
computerized cognitive behavior therapy: Effects on anx-
iety, depression, attentional control, and interpretive bias.
J Consult Clin Psychol 2012; 80: 10211033.
8. Titov N, Andrews G, Choi I, et al. Shyness 3:
Randomized controlled trial of guided versus unguided
internet-based CBT for social phobia. Aust N Z J
Psychiatry 2008; 42: 10301040.
9. Berger T, Caspar F, Richardson R, et al. Internet-based
treatment of social phobia: A randomized controlled trial
comparing unguided with two types of guided self-help.
Behav Res Ther 2011; 49: 158169.
10. Mayo-Wilson E and Montgomery P. Media-delivered
cognitive behavioural therapy and behavioural therapy
(self-help) for anxiety disorders in adults. Cochrane
Database Syst Rev 2013; (9): CD005330.
11. Connor KM, Davidson JRT, Churchill EL, et al.
Psychometric properties of the social phobia inventory
(SPIN). New self-rating scale. Br J Psychiatry 2000;
176: 379–386.
12. Todkill D and Powell J. Participant experiences of
an internet-based intervention and randomised con-
trol trial: Interview study. BMC Public Health 2013; 13:
17.
13. Powell J, Hamborg T, Stallard N, et al. Effectiveness of a
web-based cognitive-behavioral tool to improve mental
well-being in the general population: Randomized con-
trolled trial. J Med Internet Res 2013; 15: e2.
14. Letamendi AM, Chavira DA and Stein MB. Issues in the
assessment of social phobia: A review. Isr J Psychiatry
Relat Sci 2009; 46: 1324.
15. Carleton RN, Collimore KC and Asmundson GJG.
Social anxiety and fear of negative evaluation:
Construct validity of the BFNE-II. J Anxiety Disord
2007; 21: 131141.
16. EatonWW,Muntaner C, Ybarra M, et al. Revision of the
Center for Epidemiologic Studies Depression (CESD)
scale. In: Maruish M (ed.) The Use of Psychological
Testing for Treatment Planning and Outcomes Assessment.
Mahwah, NJ: Lawrence ErlbaumAssociates, 2004.
17. Maheswaran H, Weich S, Powell J, et al. Evaluating
the responsiveness of the Warwick Edinburgh Mental
Powell et al. 7
Well-Being Scale (WEMWBS): Group and individual
level analysis. Health Qual Life Outcomes 2012: 10: 156.
18. Ware JE Jr. and Sherbourne CD. The MOS 36-item
short-form health survey (SF-36). I. Conceptual frame-
work and item selection. Med Care 1992; 30: 473483.
19. Schulz KF, Altman DG and Moher D. CONSORT 2010
Statement: Updated guidelines for reporting parallel
group randomised trials. BMJ 2010; 340: c332.
20. Emsley R, Dunn G and White IR. Mediation and mod-
eration of treatment effects in randomised controlled
trials of complex interventions. Stat Methods Med Res
2010; 19: 237270.
21. MacKinnon DP, Lockwood CM, Hoffman JM, et al.
A comparison of methods to test mediation and other
intervening variable effects. Psychol Methods 2002; 7: 83.
8 DIGITAL HEALTH
